HUBUNGAN KADAR INSULIN PUASA DENGAN KADAR GULA DARAH PUASA DAN KENDALI HBA1C PADA KELOMPOK LANSIA
Main Article Content
Abstract
Pendahuluan: Diabetes melitus merupakan penyebab utama morbiditas global, dengan prevalensi yang terus meningkat, terutama pada populasi lansia. Pengukuran gula darah puasa (GDP) dan HbA1c sering digunakan untuk mengevaluasi kontrol glikemik, namun memiliki keterbatasan dalam mencerminkan dinamika sekresi dan sensitivitas insulin. Tujuan: Penelitian ini bertujuan untuk menganalisis hubungan antara kadar insulin puasa dengan GDP dan HbA1c terutama pada populasi lansia. Metode: Desain studi penelitian ini adalah potong lintang pada 41 lansia di Panti Santa Anna pada November 2023. Analisis statistik menggunakan uji Spearman. Hasil: Analisa korelasi Spearman-rho antara kadar insulin puasa dengan kadar gula darah puasa menunjukkan tidak adanya hubungan bermakna antara kadar insulin puasa dengan kadar gula darah puasa, namun penelusuran secara klinis menunjukkan korelasi positif lemah (p: 0,329, r: 0.156). Kadar insulin puasa terhadap kadar HbA1c juga menunjukkan tidak adanya hubungan bermakna, namun secara klinis berkorelasi positif lemah (p: 0,256, r: 0,182). Kesimpulan: Penelitian ini ingin melihat korelasi positif secara klinis antara kadar insulin puasa dan parameter metabolik diabetes, yang dapat tersamarkan oleh mekanisme kompensasi resistensi insulin serta proses inflamasi dan gangguan metabolik. Penelitian lebih lanjut diperlukan untuk memahami hubungan sebab-akibat antara kedua parameter tersebut dengan kadar insulin puasa secara mendalam sehingga dapat mengoptimalkan target pengobatan dan mencegah komplikasi lebih lanjut.
Article Details
Section

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Naskah yang diterima adalah naskah asli yang belum pernah dimuat dalam jurnal lain dan tidak sedang dalam proses untuk dimuat dalam majalah lain dalam waktu yang bersamaan. Naskah yang diterbitkan merupakan hak milik penerbit dan tidak akan dikembalikan, sedangkan naskah yang dinilai tidak layak diterbitkan akan dikembalikan. Naskah yang masuk akan dinilai oleh mitra bestari. Tim editor mempunyai hak melakukan pengeditan sesuai gaya selingkung untuk naskah yang akan diterbitkan.
References
Bannigida, D. M., Nayak, B. S., & Vijayaraghavan, R. (2020). Insulin resistance and oxidative marker in women with PCOS. Archives of Physiology and Biochemistry, 126(2), 183–186. https://doi.org/10.1080/13813455.2018.1499120
Bjornstad, P., & Eckel, R. H. (2018). Pathogenesis of Lipid Disorders in Insulin Resistance: a Brief Review. In Current Diabetes Reports (Vol. 18, Issue 12). Current Medicine Group LLC 1. https://doi.org/10.1007/s11892-018-1101-6
Eckstein, S. S., Weigert, C., & Lehmann, R. (2017). Divergent Roles of IRS (Insulin Receptor Substrate) 1 and 2 in Liver and Skeletal Muscle. Current Medicinal Chemistry, 24(17). https://doi.org/10.2174/0929867324666170426142826
Ikegami, H., Hiromine, Y., & Noso, S. (2022). Insulin‐dependent diabetes mellitus in older adults: Current status and future prospects. Geriatrics & Gerontology International, 22(8), 549–553. https://doi.org/10.1111/ggi.14414
Jaitin, D. A., Adlung, L., Thaiss, C. A., Weiner, A., Li, B., Descamps, H., Lundgren, P., Bleriot, C., Liu, Z., Deczkowska, A., Keren-Shaul, H., David, E., Zmora, N., Eldar, S. M., Lubezky, N., Shibolet, O., Hill, D. A., Lazar, M. A., Colonna, M., … Amit, I. (2019). Lipid-Associated Macrophages Control Metabolic Homeostasis in a Trem2-Dependent Manner. Cell, 178(3), 686-698.e14. https://doi.org/10.1016/j.cell.2019.05.054
Janssen, J. A. M. J. L. (2021). Hyperinsulinemia and Its Pivotal Role in Aging, Obesity, Type 2 Diabetes, Cardiovascular Disease and Cancer. International Journal of Molecular Sciences, 22(15), 7797. https://doi.org/10.3390/ijms22157797
Jiang, S., Yu, T., Di, D., Wang, Y., & Li, W. (2024). Worldwide burden and trends of diabetes among people aged 70 years and older, 1990–2019: A systematic analysis for the Global Burden of Disease Study 2019. Diabetes/Metabolism Research and Reviews, 40(3). https://doi.org/10.1002/dmrr.3745
Kerr, A. G., Andersson, D. P., Dahlman, I., Rydén, M., & Arner, P. (2023). Adipose Insulin Resistance Associates with Dyslipidemia Independent of Liver Resistance and Involves Early Hormone Signaling. Arteriosclerosis, Thrombosis, and Vascular Biology, 43(6), 1054–1065. https://doi.org/10.1161/ATVBAHA.123.319227
King, A. B. (2015). Misled by the Morning “Fasting” Plasma Glucose. Journal of Diabetes Science and Technology, 9(6), 1342–1345. https://doi.org/10.1177/1932296815586425
Kurniawan, L. B. (2024). HbA1c As Diabetes Mellitus Biomarker and Its Methods Evolution. Indonesian Journal of Clinical Pathology and Medical Laboratory, 30(2), 191–196. www.indonesianjournalofclinicalpathology.org
Lieb, W., de Oliveira, C. M., Pan, S., Echouffo-Tcheugui, J. B., Weber, K. S., Vasan, R. S., & Xanthakis, V. (2022). Clinical correlates of plasma insulin levels over the life course and association with incident type 2 diabetes: the Framingham Heart Study. BMJ Open Diabetes Research & Care, 10(1), e002581. https://doi.org/10.1136/bmjdrc-2021-002581
Milita, F., Handayani, S., & Setiaji, B. (2021). Kejadian Diabetes Mellitus Tipe II pada Lanjut Usia di Indonesia (Analisis Riskesdas 2018). Jurnal Kedokteran Dan Kesehatan, 17(1), 9–20. https://jurnal.umj.ac.id/index.php/JKK
Nolan, C. J., & Prentki, M. (2019). Insulin resistance and insulin hypersecretion in the metabolic syndrome and type 2 diabetes: Time for a conceptual framework shift. Diabetes and Vascular Disease Research, 16(2), 118–127. https://doi.org/10.1177/1479164119827611
Ormazabal, V., Nair, S., Elfeky, O., Aguayo, C., Salomon, C., & Zuñiga, F. A. (2018). Association between insulin resistance and the development of cardiovascular disease. In Cardiovascular Diabetology (Vol. 17, Issue 1). BioMed Central Ltd. https://doi.org/10.1186/s12933-018-0762-4
Park, S. K., Jung, J. Y., Choi, W. J., Kim, Y. H., Kim, H. S., Ham, W. T., Shin, H., & Ryoo, J.-H. (2014). Elevated fasting serum insulin level predicts future development of hypertension. International Journal of Cardiology, 172(2), 450–455. https://doi.org/10.1016/j.ijcard.2014.01.087
Pennings, N., Jaber, J., & Ahiawodzi, P. (2018). Ten‐year weight gain is associated with elevated fasting insulin levels and precedes glucose elevation. Diabetes/Metabolism Research and Reviews, 34(4). https://doi.org/10.1002/dmrr.2986
Ramesh, R., Pandurangan, V., Madhavan, S., Srinivasan, D., Bhaskar, E., Marappa, L., Nair, A. M., Rajendran, V., & Varadaraj, P. (2022). Comparison of Fasting Insulin Level, Homeostatic Model of Insulin Resistance, and Lipid Levels between Patients with Primary Hypertension and Normotensive Subjects. Rambam Maimonides Medical Journal, 13(2), e0009. https://doi.org/10.5041/RMMJ.10468
Ridwanto, M., Indarto, D., & Hanim, D. (2020). Factors Affecting Fasting Blood Glucose in Patients with Type 2 Diabetes Mellitus. International Journal of Nutrition Sciences, 5(1), 13–18. https://doi.org/10.30476/IJNS.2020.84492.1048
Saeedi, P., Petersohn, I., Salpea, P., Malanda, B., Karuranga, S., Unwin, N., Colagiuri, S., Guariguata, L., Motala, A. A., Ogurtsova, K., Shaw, J. E., Bright, D., & Williams, R. (2019). Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Research and Clinical Practice, 157, 107843. https://doi.org/10.1016/j.diabres.2019.107843
Wang, F., Han, L., & Hu, D. (2017). Fasting insulin, insulin resistance and risk of hypertension in the general population: A meta-analysis. Clinica Chimica Acta, 464, 57–63. https://doi.org/10.1016/j.cca.2016.11.009
Wu, H., & Ballantyne, C. M. (2020). Metabolic Inflammation and Insulin Resistance in Obesity. In Circulation Research (Vol. 126, Issue 11, pp. 1549–1564). Lippincott Williams and Wilkins. https://doi.org/10.1161/CIRCRESAHA.119.315896
Xing, J., & Chen, C. (2022). Hyperinsulinemia: beneficial or harmful or both on glucose homeostasis. American Journal of Physiology-Endocrinology and Metabolism, 323(1), E2–E7. https://doi.org/10.1152/ajpendo.00441.2021
Y. Younis, H., A. Thanoon, I., N. Fadhil, N., & M. Merkhan, M. (2022). Effect of Zinc as an Add-On to Metformin Therapy on Glycemic control, Serum Insulin, and C-peptide Levels and Insulin Resistance in Type 2 Diabetes Mellitus Patient. Research Journal of Pharmacy and Technology, 1184–1188. https://doi.org/10.52711/0974-360X.2022.00198
Zhao, X., An, X., Yang, C., Sun, W., Ji, H., & Lian, F. (2023). The crucial role and mechanism of insulin resistance in metabolic disease. In Frontiers in Endocrinology (Vol. 14). Frontiers Media S.A. https://doi.org/10.3389/fendo.2023.1149239